Annual FCF
-$14.14 M
-$3.58 M-33.91%
31 December 2023
Summary:
CNS Pharmaceuticals annual free cash flow is currently -$14.14 million, with the most recent change of -$3.58 million (-33.91%) on 31 December 2023. During the last 3 years, it has fallen by -$6.81 million (-92.80%). CNSP annual FCF is now -1874.30% below its all-time high of -$716.40 thousand, reached on 31 December 2018.CNSP Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly FCF
-$6.80 M
-$5.15 M-312.02%
30 September 2024
Summary:
CNS Pharmaceuticals quarterly free cash flow is currently -$6.80 million, with the most recent change of -$5.15 million (-312.02%) on 30 September 2024. Over the past year, it has dropped by -$3.42 million (-101.30%). CNSP quarterly FCF is now -8122.49% below its all-time high of -$82.70 thousand, reached on 31 March 2019.CNSP Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM FCF
-$14.18 M
-$3.42 M-31.80%
30 September 2024
Summary:
CNS Pharmaceuticals TTM free cash flow is currently -$14.18 million, with the most recent change of -$3.42 million (-31.80%) on 30 September 2024. Over the past year, it has dropped by -$270.20 thousand (-1.94%). CNSP TTM FCF is now -17047.52% below its all-time high of -$82.70 thousand, reached on 31 March 2019.CNSP TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CNSP Free Cash Flow Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -33.9% | -101.3% | -1.9% |
| 3 y3 years | -92.8% | -240.8% | -20.7% |
| 5 y5 years | -1874.3% | -1697.5% | -1205.4% |
CNSP Free Cash Flow High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -92.8% | at low | -312.0% | at low | -34.3% | at low |
| 5 y | 5 years | -1874.3% | at low | -1697.5% | at low | -1205.4% | at low |
| alltime | all time | -1874.3% | at low | -8122.5% | at low | <-9999.0% | at low |
CNS Pharmaceuticals Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$6.80 M(+312.0%) | -$14.18 M(+31.8%) |
| June 2024 | - | -$1.65 M(-48.3%) | -$10.76 M(-14.0%) |
| Mar 2024 | - | -$3.19 M(+25.7%) | -$12.51 M(-11.5%) |
| Dec 2023 | -$14.14 M(+33.9%) | -$2.54 M(-24.9%) | -$14.14 M(+1.7%) |
| Sept 2023 | - | -$3.38 M(-0.7%) | -$13.91 M(+12.7%) |
| June 2023 | - | -$3.40 M(-29.5%) | -$12.35 M(+0.3%) |
| Mar 2023 | - | -$4.82 M(+109.3%) | -$12.31 M(+16.5%) |
| Dec 2022 | -$10.56 M(-22.0%) | -$2.31 M(+27.1%) | -$10.56 M(-8.1%) |
| Sept 2022 | - | -$1.81 M(-46.1%) | -$11.50 M(-1.6%) |
| June 2022 | - | -$3.37 M(+9.4%) | -$11.68 M(-12.3%) |
| Mar 2022 | - | -$3.08 M(-5.0%) | -$13.31 M(-1.7%) |
| Dec 2021 | -$13.54 M | -$3.24 M(+62.3%) | -$13.54 M(+15.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2021 | - | -$2.00 M(-60.1%) | -$11.75 M(+6.5%) |
| June 2021 | - | -$5.00 M(+50.9%) | -$11.03 M(+25.5%) |
| Mar 2021 | - | -$3.31 M(+128.9%) | -$8.79 M(+19.8%) |
| Dec 2020 | -$7.34 M(+105.3%) | -$1.45 M(+13.6%) | -$7.34 M(-12.4%) |
| Sept 2020 | - | -$1.27 M(-53.8%) | -$8.38 M(+12.0%) |
| June 2020 | - | -$2.75 M(+47.9%) | -$7.48 M(+39.8%) |
| Mar 2020 | - | -$1.86 M(-25.2%) | -$5.35 M(+49.8%) |
| Dec 2019 | -$3.57 M(+398.8%) | -$2.49 M(+557.5%) | -$3.57 M(+229.0%) |
| Sept 2019 | - | -$378.30 K(-39.5%) | -$1.09 M(+53.4%) |
| June 2019 | - | -$625.30 K(+656.1%) | -$708.00 K(+756.1%) |
| Mar 2019 | - | -$82.70 K | -$82.70 K |
| Dec 2018 | -$716.40 K | - | - |
FAQ
- What is CNS Pharmaceuticals annual free cash flow?
- What is the all time high annual FCF for CNS Pharmaceuticals?
- What is CNS Pharmaceuticals annual FCF year-on-year change?
- What is CNS Pharmaceuticals quarterly free cash flow?
- What is the all time high quarterly FCF for CNS Pharmaceuticals?
- What is CNS Pharmaceuticals quarterly FCF year-on-year change?
- What is CNS Pharmaceuticals TTM free cash flow?
- What is the all time high TTM FCF for CNS Pharmaceuticals?
- What is CNS Pharmaceuticals TTM FCF year-on-year change?
What is CNS Pharmaceuticals annual free cash flow?
The current annual FCF of CNSP is -$14.14 M
What is the all time high annual FCF for CNS Pharmaceuticals?
CNS Pharmaceuticals all-time high annual free cash flow is -$716.40 K
What is CNS Pharmaceuticals annual FCF year-on-year change?
Over the past year, CNSP annual free cash flow has changed by -$3.58 M (-33.91%)
What is CNS Pharmaceuticals quarterly free cash flow?
The current quarterly FCF of CNSP is -$6.80 M
What is the all time high quarterly FCF for CNS Pharmaceuticals?
CNS Pharmaceuticals all-time high quarterly free cash flow is -$82.70 K
What is CNS Pharmaceuticals quarterly FCF year-on-year change?
Over the past year, CNSP quarterly free cash flow has changed by -$3.42 M (-101.30%)
What is CNS Pharmaceuticals TTM free cash flow?
The current TTM FCF of CNSP is -$14.18 M
What is the all time high TTM FCF for CNS Pharmaceuticals?
CNS Pharmaceuticals all-time high TTM free cash flow is -$82.70 K
What is CNS Pharmaceuticals TTM FCF year-on-year change?
Over the past year, CNSP TTM free cash flow has changed by -$270.20 K (-1.94%)